Consistent with prior international studies, we observed that higher TNF-α, IL-6, and CRP levels correlate with advanced tumor stage and worse outcomes.14,15 These findings align with the understanding that chronic inflammation promotes immunosuppression and glioma progression. The gene discussed is IL6; the disease is neoplasm.